We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
The pharmacokinetics, pharmacodynamics and tolerability of dabigatran etexilate, a new oral direct thrombin inhibitor, in healthy male subjects.
- Authors
Stangier, Joachim; Rathgen, Karin; Stähle, Hildegard; Gansser, Dietmar; Roth, Willy
- Abstract
The novel direct thrombin inhibitor (DTI), dabigatran etexilate (Boehringer Ingelheim Pharma GmbH & Co. KG), shows potential as an oral antithrombotic agent. Two double-blind, randomized trials were undertaken to investigate the pharmacokinetics (PK), pharmacodynamics (PD) and tolerability of orally administered dabigatran etexilate in healthy male subjects.
- Publication
British journal of clinical pharmacology, 2007, Vol 64, Issue 3, p292
- ISSN
0306-5251
- Publication type
Journal Article
- DOI
10.1111/j.1365-2125.2007.02899.x